Request Free Sample
×
South America Morphine Market
ID: MRFR/HC/49744-HCR
200 Pages
May 2025
South America Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) andBy Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035
Industry Developments
The South America Morphine Market has been witnessing notable developments recently, particularly with companies such as Dr. Reddy's Laboratories, Mundipharma, and Sun Pharmaceutical actively participating in market expansion initiatives. In August 2023, AbbVie launched a new formulation aimed at improving patient access to pain management solutions, which has been a focal point for many companies amid increasing regulatory scrutiny on opioid prescriptions. Moreover, GSK and Novartis have reported collaborations aimed at enhancing research capabilities in pain management therapies that utilize morphine. In terms of mergers and acquisitions, AstraZeneca has focused on acquiring biotech firms that hold promising analgesic potentials, with talks confirmed in September 2023, reflecting a strategic shift in approach to morphine-related portfolios. Over the past few years, particularly in June 2022, regulatory changes in Brazil have shifted the landscape, allowing for enhanced production capabilities and accessibility of morphine to treat chronic pain. The valuation growth in the market indicates an increase in demand for morphine as more patients seek effective pain management solutions, greatly impacting companies like Hikma Pharmaceuticals and Roche, who are expanding their market strategies in South America.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.62(USD Billion) |
| MARKET SIZE 2024 | 1.73(USD Billion) |
| MARKET SIZE 2035 | 3.24(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.878% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Dr. Reddy's Laboratories, Mundipharma, GSK, Sun Pharmaceutical, Novartis, AbbVie, Hikma Pharmaceuticals, Roche, Sanofi, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, AstraZeneca, Lupin Pharmaceuticals |
| SEGMENTS COVERED | Dosage Form, Application, Distribution Channel, End User, Regional |
| KEY MARKET OPPORTUNITIES | Growing cancer prevalence, Demand for pain management, Increased palliative care services, Expanding pharmaceutical distribution channels, Regulatory reforms enhancing access |
| KEY MARKET DYNAMICS | regulatory challenges, rising cancer prevalence, opioid addiction concerns, pharmaceutical innovations, distribution network limitations |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
FAQs
What is the expected market size of the South America Morphine Market in 2024?
The South America Morphine Market is expected to be valued at 1.73 USD Billion in 2024.
What will be the market size of the South America Morphine Market in 2035?
In 2035, the South America Morphine Market is projected to reach a value of 3.24 USD Billion.
What is the expected compound annual growth rate (CAGR) for the South America Morphine Market from 2025 to 2035?
The expected CAGR for the South America Morphine Market from 2025 to 2035 is 5.878%.
Which region is expected to dominate the South America Morphine Market by 2035?
By 2035, Brazil is expected to dominate the South America Morphine Market with an estimated value of 1.131 USD Billion.
What is the market size for Morphine Injection in 2024?
Morphine Injection is valued at 0.8 USD Billion in the year 2024.
How much is the Oral Morphine segment expected to grow by 2035?
The Oral Morphine segment is expected to increase in value to 1.05 USD Billion by 2035.
What are the major players in the South America Morphine Market?
Key players in the market include Dr. Reddy's Laboratories, Mundipharma, GSK, and Sun Pharmaceutical.
What is the expected market value for other dosage forms of Morphine by 2035?
The market for other dosage forms of Morphine is expected to reach 0.7 USD Billion by 2035.
What is the projected market size of Morphine in Argentina for 2035?
Argentina's Morphine market is forecasted to grow to 0.481 USD Billion by 2035.
What growth opportunities exist for the South America Morphine Market?
Growth opportunities are driven by rising demand for pain management and advancements in drug delivery systems.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment